ES0169501022
ES0169501022
PHARMA MAR, S.A.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 1.2B EUR | 1.31B EUR | 1.51B EUR |
Enterprise Value | 1.08B EUR | 1.33B EUR | 1.51B EUR |
Valuation Multiples | |||
Trailing P/E | 23.07x | 16.44x | 19.77x |
Forward P/E | 10.59x | -- | -- |
Price to Sales | 5.48x | 4.71x | 5.68x |
Price to Book | 4.8x | 5.21x | 6.06x |
EV/Revenue | 4.94x | 4.81x | 5.67x |
EV/EBITDA | 24.11x | 17.97x | 20.87x |
Price to FCF (P/FCF) | 29.25x | 30.16x | 42.61x |
EV/FCF | 26.37x | 30.77x | 42.57x |
FCF Yield | 3.42% | 3.32% | 2.35% |